Because it’s already been decarboxylated, there is no need to vape CBD isolate to recieve its benefits. You can simply ingest the isolate and let it go to work. Also keep in mind that consuming isolate (as opposed to smoking a high CBD strain of cannabis) yields you higher concentrations of CBD in smaller amounts, making it a great medicine for those who need it.
CBD is a powerful anti-inflammatory and regulator of gastric motility, which makes it a potential therapy for IBS, Crohn’s disease, and colitis.
CBD is a powerful antioxidant, which makes it a preventative of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS. Its antioxidant properties also make it an age-reduction skin therapy.
CBD’s anti-inflammatory quality has been found to alleviate the symptoms of multiple sclerosis. Because of its antioxidant properties, it may also prevent multiple sclerosis and/or prevent the disease from escalating.
CBD’s anti-inflammatory properties are also responsible for its effective treatment of chronic pain in patients with conditions ranging from fibromyalgia to arthritis
CBD’s antipsychotic properties make it a viable alternative to pharmaceuticals for schizophrenic patients. Generally, CBD is a great alternative for pharmaceuticals used to treat a host of diseases. This is a big deal since pharmaceuticals are responsible for the epidemic of prescription drug abuse ripping through our country and the vast amount of side effects either debilitating or killing pharmaceutical patients.
CBD has been found to not only effectively treat insomnia, but to create stable sleep patterns and, consequently, long-term relief from sleeplessness.
CBD’s interaction with the endocannabinoid system helps to reduce nausea, particularly in chemo patients. Studies show that CBD actively destroys cancer cells, which makes it a potential non-toxic, painless alternative to chemotherapy.
Despite the extensive research indicating otherwise, the DEA has classified CBD as a Schedule 1 drug, or a substance with no medical value and a high potential for abuse. This is at once laughable, and very, very tragic.
Cannabinoids are incredibly important because of their effect on the human body. Endocannabinoid receptors are located throughout our bodies, and when these receptors are stimulated (whether by external cannabinoids or the ones already present within us), they work to maintain homeostasis. These receptors comprise what is known as the endocannabinoid system.
THC is the most well-known cannabinoid because of its psychotropic properties—it gets you high, and that’s because of the way that it interacts with the endocannabinoid system. Although high THC levels are often huge draws for pot consumers, too much THC can have negative effects including paranoia, anxiety, and panic attacks. Additionally, there is a huge market purely interested in the therapeutic aspects of cannabis, not the psychoactive ones.
Therapeutic consumers tend to look for strains that have low concentrations of THC but high concentrations of CBD
While THC is a very cool cannabinoid, CBD is sort of miraculous. It has an array of therapeutic benefits ranging from cancer prevention and treatment to pain relief. It basically treats every disease ever, and that’s only sort of hyperbole. Let me show you what I mean.
So all of those incredible effects of CBD that I mentioned earlier? Well, they come with a bit of a caveat known as the entourage effect. The cannabinoids present in the cannabis plant work together to produce the effect the consumer experiences; this interaction of cannabinoids is known as the entourage effect.
THC and CBD work together. CBD organically blocks the potency of THC, which makes the high experienced by the consumer manageable and pleasant. THC works with CBD to amplify its medicinal qualities. Additionally, THC has medicinal qualities of its own that are completely forgone by CBD isolate. Cannabis has more to offer than just cannabinoids; terpenes, the chemical compounds that create the plant’s scent, are also present in cannabis.
Terpenes don’t exclusively give cannabis strains their unique smells; they contain therapeutic qualities as well.
For example, linalool has been used as an antidepressant, sleep-aid, and an anti-convulsant. Another terpene, caryophyllene, is a known antioxidant, antidepressant, and anti-inflammatory. There are many more terpenes, but you can’t catch ‘em all if you go with isolate because they’ve been removed.
Removing all other molecules from the cannabis plant potentially removes—or at least seriously alters—the therapeutic effects that naturally occur when those compounds are working synergistically. In fact, studies show that when used in combination with THC, it takes less CBD to produce the desired medicinal outcome than when CBD isolate is used instead.
The endocannabinoid system (ECS) is a biological system composed of endocannabinoids, which are endogenous lipid-based retrograde neurotransmitters that bind to cannabinoid receptors, and cannabinoid receptor proteins that are expressed throughout the mammalian central nervous system (including the brain) and peripheral nervous system. The endocannabinoid system is involved in regulating a variety of physiological and cognitive processes including fertility, pregnancy, during pre- and postnatal development, appetite, pain-sensation, mood, and memory, and in mediating the pharmacological effects of cannabis. The ECS is also involved in mediating some of the physiological and cognitive effects of voluntary physical exercise in humans and other animals, such as contributing to exercise-induced euphoria as well as modulating locomotor activity and motivational salience for rewards. In humans, the plasma concentration of certain endocannabinoids (i.e., anandamide) have been found to rise during physical activity; since endocannabinoids can effectively penetrate the blood–brain barrier, it has been suggested that anandamide, along with other euphoriant neurochemicals, contributes to the development of exercise-induced euphoria in humans, a state colloquially referred to as a runner's high.
Two primary endocannabinoid receptors have been identified: CB1, first cloned in 1990; and CB2, cloned in 1993. CB1 receptors are found predominantly in the brain and nervous system, as well as in peripheral organs and tissues, and are the main molecular target of the endocannabinoid ligand (binding molecule), anandamide, as well as its mimetic phytocannabinoid, THC. One other main endocannabinoid is 2-arachidonoylglycerol (2-AG) which is active at both cannabinoid receptors, along with its own mimetic phytocannabinoid, CBD. 2-AG and CBD are involved in the regulation of appetite, immune system functions and pain management